TOKYO--(BUSINESS WIRE)--Early results were reported from an independent study in Japan using adipose-derived stem and regenerative cells for breast augmentation. Early results on the first three patients from this investigator-initiated study showed the increase in breast volume was maintained at three months and that the tissue remained soft and natural. The findings were reported earlier this week by the investigator, Tatsuro Kamakura, M.D., Chief Medical Officer of Cosmetic Surgery Seishin, at the 94th Bi-Annual Congress of the Japan Society of Aesthetic Surgery (www.biyou-clinic.jp/jsas/).
